Insiders Gilead Sciences, Inc.

Equities

GILD

US3755581036

Pharmaceuticals

Market Closed - Nasdaq Other stock markets 16:00:00 2025-01-17 EST			5-day change	1st Jan Change
91.84 ^USD	+0.21%		+2.18%	-0.57%

01-15	Gilead Sciences, US government settle patent case over HIV prevention drugs	RE
01-13	Gilead to Seek M&A	CI

Insiders

Gilead Sciences Names Sanofi's Berger as Next Chief Medical Officer	12-12	DJ
Gilead appoints Sanofi official Dietmar Berger as next chief medical officer	12-12	RE
Gilead Sciences Names Dietmar Berger as Chief Medical Officer	12-12	MT
Gilead Sciences Insider Sold Shares Worth $23,065,271, According to a Recent SEC Filing	12-03	MT
IDEAYA Biosciences, Inc. Appoints Stu Dorman as Chief Commercial Officer	11-18	CI
Savills Appointed by Receivers to Market ?60 Million Dublin Offices Let to WeWork	24-10-31	CI
Echo IQ Names Chief Executive	24-10-08	MT
Kyverna Therapeutics Names Warner Biddle CEO	24-09-16	MT
Kyverna Therapeutics, Inc. Announces CEO Changes	24-09-16	CI
Gilead Sciences Insider Sold Shares Worth $1,795,287, According to a Recent SEC Filing	24-09-16	MT
Gilead Sciences Insider Sold Shares Worth $2,459,577, According to a Recent SEC Filing	24-09-13	MT
Gilead Sciences Insider Sold Shares Worth $742,299, According to a Recent SEC Filing	24-08-29	MT
Cytokinetics, Incorporated Announces the Appointment of Brett Pletcher as Executive Vice President and Chief Legal Officer	24-08-15	CI
Gilead Sciences Insider Sold Shares Worth $406,150, According to a Recent SEC Filing	24-08-14	MT
Fate Therapeutics, Inc. Appoints Neely Mozaffarian to its Board of Directors	24-07-31	CI
Gilead Sciences Chief Medical Officer Merdad Parsey to Leave	24-07-17	MT
Gilead Sciences Chief Medical Officer to Step Down	24-07-17	DJ
Merdad Parsey to Leave Gilead Sciences, Inc. as Chief Medical Officer, Effective Early 2025	24-07-17	CI
Sector Update: Health Care Stocks Rise Tuesday Afternoon	24-06-04	MT
Gilead Sciences, Inc. Announces Retirement of Kevin E. Lofton from the Board, Effective May 8, 2024	24-03-14	CI
Gilead Sciences Insider Sold Shares Worth $744,984, According to a Recent SEC Filing	24-03-01	MT
AI-Media Technologies Appoints Chair; Shares up 15%	24-02-25	MT
Gilead Sciences, Inc. Appoints Ted Love to Board of Directors	24-02-01	CI

Become a member to access more news.

100% Free Registration

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Insiders Gilead Sciences, Inc.

Equities

GILD

US3755581036

Pharmaceuticals

Insiders

Filters